Focused Technology Research and Development (R01 Clinical Trial Not Allowed) | PAR 25 203

Opportunity Information: Apply for PAR 25 203

The Focused Technology Research and Development funding opportunity (PAR-25-203) is an NIH grant program that uses the R01 mechanism to support technology development projects aligned with the mission of the National Institute of General Medical Sciences (NIGMS). The central purpose is to fund work that is strictly about creating or substantially advancing a technology that can enable the acquisition of biomedical knowledge. In other words, the emphasis is on building new tools, methods, platforms, or approaches that will make future biomedical research possible or meaningfully better, rather than on using an existing tool to answer a specific biological or clinical question. Clinical trials are not allowed under this NOFO, reinforcing that the scope is technology R and D rather than clinical intervention testing.

Projects are expected to be strongly justified on two fronts: technical innovation and practical utility for biomedical research. The proposed work should clearly explain what is technically new (for example, a novel measurement approach, a new modality, a step-change improvement in sensitivity, throughput, accuracy, scalability, automation, or cost), and why that innovation will matter to researchers studying a broad range of biomedical problems. The intended outcome should be a technology that pushes the state of the art forward in a significant way, not an incremental tweak. Importantly, the NOFO also signals that the technology needs to be sufficiently characterized by the end of the project. That generally means the deliverable should be more than a concept or prototype sketch; it should be validated enough that other researchers could realistically apply it to diverse biomedical research questions, with performance demonstrated and key limitations understood.

This opportunity falls under a health-related funding activity category (CFDA 93.859) and is offered by the National Institutes of Health. The program is discretionary and supports awards as grants. While the listing provided does not specify an award ceiling or expected number of awards, the presence of an open period through an original closing date of January 7, 2028 indicates a long-running, standing opportunity where applicants can prepare proposals over multiple cycles, following NIH submission schedules and the detailed NOFO requirements.

Eligibility is broad and includes many common NIH applicant types across government, academia, nonprofit, and industry. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); and small businesses. The NOFO also highlights additional eligible applicant categories, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and applicants from U.S. territories or possessions.

Restrictions on foreign participation are explicitly stated. Non-domestic (non-U.S.) entities (foreign organizations) are not eligible to apply, and non-domestic components of U.S. organizations are not eligible to apply. At the same time, the NOFO allows “foreign components” as defined in the NIH Grants Policy Statement, meaning a U.S.-based applicant may include certain international elements in the project when justified and compliant with NIH policy, even though the applicant organization itself must be domestic and the project cannot be run through a non-U.S. organizational component.

Overall, this NOFO is best suited for applicants proposing a clearly defined technology development plan with measurable technical milestones, compelling evidence that the final product will be broadly enabling for biomedical research, and enough characterization and demonstration to show that the technology is ready to be adopted or further extended by the wider research community.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "Focused Technology Research and Development (R01 Clinical Trial Not Allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.859.
• This funding opportunity was created on 2024-11-14.
• Applicants must submit their applications by 2028-01-07.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PAR 25 203

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: